Attachment A Pricing Sheet .xlsx

The file is an Attachment A Pricing Sheet for a biorelevant characterization system for subcutaneous formulations, associated with Solicitation Number 75F401F25R00066 issued by the Department of Health and Human Services Food and Drug Administration. The pricing template outlines a base period and four option years for purchasing and installing an in vitro system, with line items including the characterization system, installation, instrument qualification, training, and post-warranty service agreements. Each period allows for pricing of the primary system and associated services, with space for quantity, unit price, and total price calculations.

The solicitation seeks an advanced in vitro system capable of characterizing subcutaneous drug injections under simulated physiological conditions, specifically designed to assess critical drug attributes for biologics, peptides, and small molecules. The system requires integrated features such as a camera, turbidity sensors, inline fiber optic probes, pH monitors, and an automated sample fraction collector. The primary objective is to expand the FDA's CDER/OPQ/OPQR capacity to evaluate pharmaceutical product quality, safety, and efficacy, with a focus on understanding drug release performance in an artificial extracellular matrix.